TIANXIN PHARMA
60323524.000.17% ( +0.04 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: TIANXIN PHARMA(603235) the Revenue is 639.76 M (+3.37%);the EBIT is 185.67 M (-25.76%);the EPS is 0.34 (-32%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.64B3.37%
----
----
EBIT
0.19B25.76%
----
----
EPS
0.3432.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf